Is There a Difference between Leads and Drugs? A Historical Perspective
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接:
https://figshare.com/articles/dataset/Is_There_a_Difference_between_Leads_and_Drugs_A_Historical_Perspective/7944836
下载链接
链接失效反馈官方服务:
资源简介:
To be considered for further development, lead structures should display the following properties: (1) simple
chemical features, amenable for chemistry optimization; (2) membership to an established SAR series; (3)
favorable patent situation; and (4) good absorption, distribution, metabolism, and excretion (ADME) properties.
There are two distinct categories of leads: those that lack any therapeutic use (i.e., “pure” leads), and those
that are marketed drugs themselves but have been altered to yield novel drugs. We have previously analyzed
the design of leadlike combinatorial libraries starting from 18 lead and drug pairs of structures (S. J. Teague
et al. Angew. Chem., Int. Ed. Engl. 1999, 38, 3743−3748). Here, we report results based on an extended
dataset of 96 lead-drug pairs, of which 62 are lead structures that are not marketed as drugs, and 75 are
drugs that are not presumably used as leads. We examined the following properties: MW (molecular weight),
CMR (the calculated molecular refractivity), RNG (the number of rings), RTB (the number of rotatable
bonds), the number of hydrogen bond donors (HDO) and acceptors (HAC), the calculated logarithm of the
n-octanol/water partition (CLogP), the calculated logarithm of the distribution coefficient at pH 7.4 (LogD74),
the Daylight-fingerprint druglike score (DFPS), and the property and pharmacophore features score (PPFS).
The following differences were observed between the medians of drugs and leads: ΔMW = 69; ΔCMR =
1.8; ΔRNG = ΔHAC =1; ΔRTB = 2; ΔCLogP = 0.43; ΔLogD74 = 0.97; ΔHDO = 0; ΔDFPS = 0.15;
ΔPPFS = 0.12. Lead structures exhibit, on the average, less molecular complexity (less MW, less number
of rings and rotatable bonds), are less hydrophobic (lower CLogP and LogD74), and less druglike (lower
druglike scores). These findings indicate that the process of optimizing a lead into a drug results in more
complex structures. This information should be used in the design of novel combinatorial libraries that are
aimed at lead discovery.
创建时间:
2019-04-03



